×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Ovarian Cancer

Feature Video
Dr Shannon Westin, a clinical investigator at the MD Anderson Cancer Center, discusses PARP inhibition for patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.
Rona Cherry
“For so long ovarian cancer has been a secret part of my life. That’s over now.”
Kelly Irvin
"I’m a work in progress. I work to heed my oncologist’s advice: Don’t spoil today by worrying about tomorrow."
Deborah Abrams Kaplan
A rare type of ovarian tumor can raise testosterone levels, causing women to develop male characteristics. The main treatments: surgery and chemotherapy.
Jessica Skarzynski
September is Ovarian Cancer Awareness Month. Here’s a round-up of the latest news and updates in this disease space.
Katie Kosko
From a return to work for Alex Trebek to a personalized Backstreet Boys concert, here’s what is making headlines in the cancer space this week.
Kristie L. Kahl
The US Preventive Services Task Force now recommends for genetic counseling and testing for survivors of certain cancer types, but many at high-risk for the disease are left off the list.
 
Jessica Skarzynski
In a new study, Zejula (niraparib) has been shown to prolong life for patients with ovarian cancer who have already undergone four or more rounds of chemotherapy.
Beth Fand Incollingo
Removing lymph nodes that appear unaffected by ovarian cancer won’t help and might hurt.
Meredith Begley and Julie Grisham
A recent study found that only a quarter of women with breast cancer and a third of women with ovarian cancer had undergone genetic testing. Memorial Sloan Kettering experts say these numbers are surprisingly low.
RoseMarie Oliver
One survivor shares how the support of the Cancer Institute at St. Francis and oncology nurse Rose Francucci helped her embrace her cancer journey with positivity.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×